HomeMarkets Markets The $6 Billion Shot at Making New Antibiotics—Before the Old Ones Fail By news November 14, 2022 0 206 FacebookTwitterPinterestWhatsApp Antimicrobials cost as much to develop as other drugs, but don’t earn the same returns. Congress could give drugmakers a boost, but time is running …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected148,776FansLike396,312FollowersFollow2,700SubscribersSubscribe Latest Articles Markets What Next Wednesday – Hyperscalers Run out of Cash! Markets The Strait of Hormuz is finally reopening but Europe’s food chain suppliers cannot afford to be complacent Markets Medication abortion: Decisions from federal courts, the FDA or Trump’s Department of Justice could try to end access via telehealth Markets Testy Tuesday – Is the Tech Wreck Just Getting Started? Energy A Massive Energy Break Coming Soon Market News Will Ukraine Make a Play on Crimea? Markets Monday Market Movement – Toy Story Makes $312M = Buy Disney (DIS) – Duh! Charts Weekly Webinar: Portfolio Review & Warsh’s First FED Meeting (6/17/2026) AI The Myth of SpaceX Markets Macron plays ‘Trump whisperer’ as the US president signs Iran ceasefire deal after a successful G7 summit Market News What the failed next generation fighter jet deal means for European defence AI Cerebras: Can a New AI Architecture Challenge NVIDIA? AI The Economics of the AI Boom Markets WTF Friday — Obama Opens His Library and Trump Cooks the Books Load more